The Global mTOR Inhibitor Torin1 Is More Effective than the mTORC1 Inhibitor, Everolimus, Alone or in Combination with Histone Deacetylase Inhibitors, in Suppressing Neuroendocrine Tumor Cell Proliferation

Míreanna comhchosúla

• Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma.
  de réir: Quan Wang, et al.
  Foilsithe / Cruthaithe: (2013-01-01)
• Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
  de réir: Liu, Qingsong, et al.
  Foilsithe / Cruthaithe: (2015)
• Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
  de réir: Heng Du, et al.
  Foilsithe / Cruthaithe: (2023-11-01)
• Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells
  de réir: Jose A. Sandoval, et al.
  Foilsithe / Cruthaithe: (2020-11-01)
• Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
  de réir: Grozinsky-Glasberg, S, et al.
  Foilsithe / Cruthaithe: (2008)